Physiotherapy Rehabilitation for People With Progressive Multiple Sclerosis: A Systematic Review

Arch Phys Med Rehabil. 2016 Jan;97(1):141-51.e3. doi: 10.1016/j.apmr.2015.07.022. Epub 2015 Aug 14.

Abstract

Objective: To assess the efficacy of physiotherapy interventions, including exercise therapy, for the rehabilitation of people with progressive multiple sclerosis.

Data sources: Five databases (Cochrane Library, Physiotherapy Evidence Database [PEDro], Web of Science Core Collections, MEDLINE, Embase) and reference lists of relevant articles were searched.

Study selection: Randomized experimental trials, including participants with progressive multiple sclerosis and investigating a physiotherapy intervention or an intervention containing a physiotherapy element, were included.

Data extraction: Data were independently extracted using a standardized form, and methodologic quality was assessed using the PEDro scale.

Data synthesis: Thirteen studies (described by 15 articles) were identified and scored between 5 and 9 out of 10 on the PEDro scale. Eight interventions were assessed: exercise therapy, multidisciplinary rehabilitation, functional electrical stimulation, botulinum toxin type A injections and manual stretches, inspiratory muscle training, therapeutic standing, acupuncture, and body weight-supported treadmill training. All studies, apart from 1, produced positive results in at least 1 outcome measure; however, only 1 article used a power calculation to determine the sample size and because of dropouts the results were subsequently underpowered.

Conclusions: This review suggests that physiotherapy may be effective for the rehabilitation of people with progressive multiple sclerosis. However, further appropriately powered studies are required.

Keywords: Exercise; Multiple sclerosis; Physical therapy modalities; Rehabilitation; Review [publication type].

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Acupuncture Therapy
  • Botulinum Toxins, Type A / therapeutic use
  • Humans
  • Multiple Sclerosis, Chronic Progressive / rehabilitation*
  • Physical Therapy Modalities*
  • Randomized Controlled Trials as Topic

Substances

  • Botulinum Toxins, Type A